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Meconium-stained amniotic fluid (MSAF) complicates approximately 5–10% of live births [1]. Its incidence is more common in 37 weeks or older babies who are 
post-mature and small for gestational age, whereas in preterm, 
its incidence is very low. Babies born with MSAF are 100-fold 
more likely to develop substantial respiratory distress than 
those born with clear amniotic fluid [2]. Intrauterine hypoxia 
may cause passage of meconium in the amniotic fluid [3,4]. 
As meconium causes severe ventilation-perfusion mismatch 
requiring respiratory support, various ventilation strategies have 
been designed for its management.
Continuous positive airway pressure (CPAP) is a 
well-established mode of respiratory support in preterm 
newborns. In meconium aspiration syndrome (MAS), application 
of CPAP can be beneficial by resolving the atelectatic alveoli 
due to injury and secondary surfactant deficiency [5-7]. About 
one-third of infants with MAS require intubation and mechanical 
ventilation (MV) [8]. Ventilatory management of the neonate 
with MAS is challenging due to the complicated pulmonary 
pathophysiology. This results from the areas of atelectasis 
and hyperinflation, in association with ventilation-perfusion 
mismatch, airway compromise, and pulmonary leak. There is 
little evidence from the clinical trials regarding the respiratory 
support of neonates with MAS. This study was done to evaluate 
the usefulness of bubble CPAP as a primary respiratory support in 
neonates admitted with MAS and to enumerate factors affecting 
CPAP failure.
MATERIALS AND METHODS
A prospective study was conducted in the neonatal intensive 
care unit (NICU) of a tertiary care teaching institution over a 
period of 2 years. Patients were recruited after getting approval 
from the Institutional ethical committee and after taking written 
consent from the parents of legal guardians of the baby. A total 
of 657 neonates were admitted to NICU with diagnosis of 
MSAF, of which 325 neonates were enrolled in the study. The 
study included all the neonates born with a history of MSAF 
with the development of respiratory distress within 6 h of life 
(Downe’s score 4–7), SpO2<90% with chest X-ray suggestive 
of MAS. Neonates with birth weight >2000 g and <4000 g and 
gestational age >34 weeks including post-matured neonates 
were included in the study. Newborn with comorbid conditions 
including congenital heart disease, chromosomal anomalies, 
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lethal congenital anomalies, and severely asphyxiated neonates 
requiring intubation at admission was excluded from the study.
Bubble CPAP was started if SpO2 <90% with oxygen at 
10 L/min and Downe’s score was 4–7. CPAP pressure and FiO2 
were adjusted to maintain a SpO2 between 89% and 95% with a 
maximum pressure limit of 6 cm and FiO2 of 100%. CPAP was 
removed when the SpO2 was >90% with FiO2 requirement <25% 
and when respiratory distress was passive (RR <60/min, no or 
mild retractions and no grunt). Post-CPAP, oxygen was given 
either with hood or with binasal oxygen prongs, as appropriate. 
Neonates with MAS who had hypoxemia (PaO2 <50 mmHg), 
hypercarbia (PaCO2 >60 mmHg) or acidosis (pH <7.25), and 
saturation <89% in oxygen-enriched environment with FiO2 
>60% were considered as candidates for MV.
The primary outcome was an improvement in Downe’s score 
and clinical condition of neonates. CPAP failure was defined as 
the need for MV, pulmonary leak syndrome, persistent pulmonary 
hypertension (PPHN), and progression of Downe’s score. 
Outcome variables were compared between the infants who failed 
CPAP and those who were successfully managed with CPAP.
Categorical variables were compared with Chi-square test, 
while continuous variables were analyzed using Student’s t-test 
for normal distribution. Significance was defined as p<0.05 for 
the predefined outcome variables and p<0.01 for other outcome 
variables explored post hoc. Odds for CPAP failure were analyzed 
using logistic regression analysis.
RESULTS
The mean birth weight of enrolled neonates was 2706±200 g and 
mean age was 37±1.2 weeks. A total of 68% of enrolled neonates 
were male and 32% were female. A total of 16% of the enrolled 
neonates were preterm, 60% were term, and 24% were post-term, 
respectively. Out of the total admitted neonates, 33.4% were 
born to mothers with pregnancy-induced hypertension, 5.8% to 
mothers with gestational diabetes mellitus; however, 38% were 
out born (n=25). Cesarean section was mode of delivery in 40% 
of neonates. Growth restriction at birth was present in 40 neonates 
most of them being born to pre-eclamptic mothers. Mean Apgar 
score at 1 min and 5 min was 6 (interquartile range [IQR] 4–7) 
and 8 (IQR 4–9), respectively (Table 1).
Meantime to start of CPAP was 0.34 h. Mean SpO2 without 
oxygen supplementation was 74.23±9%, mean Downe’s score 
before starting CPAP was 6 (IQR 4–7), and mean RR and heart 
rate were 86±8 and 72±12/min, respectively (Table 2). Mean 
highest peak end-expiratory pressure (PEEP) during CPAP was 
6. A total of 320 chest radiographs were available for analysis. 
Hyperinflation on chest radiograph (>8 intercostal spaces) was 
seen in 254 patients (79%), moderate infiltrates in 117 (36%) 
infants, and bilateral severe infiltrates were seen in 136 (42%) 
infants. A significant decline in the need for FiO2, mean Downe’s 
score, mean RR, and heart rate was observed from the baseline 
to 8 h of CPAP. Median duration of CPAP was 38.5 h (range: 
12–54 h), median duration of oxygen supplementation was 74.8 
h (range: 24–168 h), and median duration of hospital stay was 
14 days (range: 8–22 days).
A total of 23 (35%) neonates developed culture-positive 
sepsis during the hospital stay. Neonatal seizures were treated 
in 250 (76%) infants. Neonates requiring sedation during 
CPAP were 46 and phenobarbitone was used for sedation. 
A total of 65 neonates (20%) had significant nasal trauma due 
to CPAP interface, and 8% (2.4) of cases developed necrotizing 
enterocolitis. A total of 30 (9.2%) neonates died of severe 
PPHN. Failure of CPAP and requirement of MV (synchronized 
intermittent mandatory ventilation mode) was observed in 
75 neonates. Reasons were increased in Downe’s score (54%), 
pulmonary leak syndrome (23%), pulmonary hemorrhage 
(19%), recurrent apnea (3%), and others (1%). On analysis, 
Table 1: CPAP success versus failure
Predictor variables Success (250) Failure (75) p-value
Birth weight in grams* 2706±200 2132±100 <0.001
Gestational age in weeks* 37±1.2 35±0.8 <0.001
Sex: Male 146 (58.4) 44 (58.7) 0.9632
IUGR 16 (40) 24(40) 0.3741
Outborn 76 (30.4) 46 (61.33) <0.0001
Saturation at start of CPAP 78±4 68±5 <0.0001
Non-vigorous baby 50 (20) 10 (13.33) 0.1923
APGAR at 1 min 4–6 160 (64) 60 (80) 0.0095
APGAR at 5 min 4–6 42 (16.8) 14 (18.7) 0.7028
Maximum PEEP during CPAP 5±0.8 7±0.8 <0.0001
PEEP after 1 h of beginning of CPAP 5±0.4 6±0.9 <0.0001
Severe infiltrates on chest X-ray 54 (21.6) 36 (48) <0.0001
FiO2 at the beginning of CPAP* 56±4 72± 2 <0.0001
Time of start of CPAP (min) 32±5 72±7 <0.0001
PPHN 120 (48) 48 (64) 0.0152
*Values are expressed in median±standard deviation, other values in percentage (n), CPAP: Continuous positive airway pressure, PEEP: Positive end-expiratory pressure, 
PPHN: Persistent pulmonary hypertension, IUGR: Intrauterine growth restriction
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factors associated with failed CPAP were outborn status, male 
sex, preterm, growth-restricted babies, high FiO2 at 1 h, and high 
PEEP at 1 h of start of CPAP. CPAP failure was more commonly 
seen in neonates with recurrent apnea.
DISCUSSION
Despite the improvement in obstetrical and neonatal care, MAS 
continues to be a neonatal disorder with high morbidity and 
mortality. Management of MAS complicated with PPHN requires 
multimodal approach which includes MV, high-frequency 
ventilation, inhaled nitric oxide, and extracorporeal membrane 
oxygenation which are not usually available in most of the NICUs 
including government sectors. CPAP being an emerging modality 
in the management of moderate-to-severe MAS is as effective as 
MV with lesser risk of pulmonary leak syndromes, pneumonia, 
and hypotension. In meconium-stained babies, MAS is more 
likely in the presence of respiratory distress starting immediately 
after birth. The current study showed that the early initiation 
of low-level bubble CPAP in neonates with MAS reduces the 
subsequent need for MV. For every five newborns with MAS 
started on bubble CPAP, four newborns were protected from MV. 
The need for MV in the first 7 days of life was significantly lower.
Many studies have been done to identify risk factors for 
developing severe MAS in live-born babies [5-9], but no study 
has been done to identify risk factors for success or failure of 
CPAP in MAS. Being outborn was an important predictor of 
CPAP failure in our study. Increased risk of unreported asphyxia, 
lack of antenatal and perinatal monitoring, poor availability of 
skilled personnel for resuscitation at birth, and delay in initiation 
of respiratory support in outborn infants may be the reasons for 
increased severity of MAS and CPAP failure in these infants. 
On subgroup analysis, outborn infants were more immature and 
a higher proportion depressed at birth compared with inborn 
infants.
Fox et al., in their retrospective analysis of records of 
14 patients with MAS, evaluated the role of CPAP for MAS. The 
study revealed that PEEP can be effective without simultaneous 
MV [10]. Malik and Gupta conducted a prospective study on 
the role of CPAP in 116 consecutive neonates suffering from 
respiratory distress including 18 babies with MAS [11]. Babies 
with respiratory distress were first treated with humidified 
oxygen by hood at a rate of 4–6 L/min. Indications for shifting 
to CPAP ventilation were failure to maintain SaO2 >85%, 
persistent or increased Downe’s score of 6 or more, and 
recurrent apneic spells. All MAS infants required CPAP with 
one failed CPAP and required MV, 12 of the 18 infants (66%) 
survived. Reasons for CPAP failure and mortality were not 
reported in the study [11].
Bhagwat et al. [12], in their prospective study, showed that out 
of enrolled 66 infants, 50 (76%) with moderate-to-severe MAS 
were managed with CPAP alone and concluded that the use of 
early CPAP resulted in a lesser need for ventilation. The duration 
of oxygen requirement, hospitalization, and ventilation is very 
similar to the results of our study. Pandita et al. [13], in their 
randomized clinical trial involving 135 infants with moderate or 
severe MAS, showed that 2 infants (3%) supported with nasal 
CPAP required subsequent MV in the first 7 days of life versus 17 
infants (25%) who were supported with hood oxygen, which was 
a significant difference. They concluded that there is reduction 
in subsequent need for MV in infants in whom nasal CPAP was 
used as initial respiratory support which is also consistent with 
the present study.
Manandhar [14], in his study involving 63 babies with 
respiratory distress, showed that 39 (61%) showed improvement 
of respiratory distress with bubble CPAP with confidence interval 
of 38–62%, whereas 24 (39%) babies required MV and other 
modalities. This is in consistent with our study. This is one of 
the first studies evaluating the role of CPAP in neonates with 
moderate-to-severe MAS. Well-defined inclusion criteria and 
uniform implementation of the study protocol are some of the 
merits of this study. The limitations of our study are lack of 
randomization, with no perinatal data in all outborn infants, and 
inability to generalize the data to all infants with MAS.
CONCLUSION
CPAP is an emerging modality in the management of moderate-
to-severe MAS and is as effective as MV with lesser risk of 
pulmonary leak syndromes, pneumonia, and hypotension. Early 
initiation of CPAP in MAS neonates decreases the need for MV 
with improved outcome.
REFERENCES
1. Plosa EJ. Cloharty and Stark’s Manual of Neonatal Care: Meconium 
Aspiration. 8th ed. Philadelphia, PA: Wolters Kluwer; 2019. p. 461.
2. Sankhyan N, Sharma VK, Sarin R, Pathania K. Predictors of meconium 
stained amniotic fluid: A possible strategy to reduce neonatal morbidity and 
mortality. J Obstet Gynecol India 2006;56:514-7.
3. Clearly GM, Wiswell TE. Meconium-stained amniotic fluid and the 
meconium aspiration syndrome: An update. Pediatr Clin North Am 
1998;45:511-29.
4. Ross MG. Meconium aspiration syndrome more than intrapartum meconium. 
N Engl J Med 2005;353:946-8.
5. Dargaville PA, Copnell B. The epidemiology of meconium aspiration 
syndrome: Incidence, risk factors, therapies, and outcome. Pediatrics 
2006;117:1712-21.
6. Raju U, Sondhi V, Patnaik SK. Meconium aspiration syndrome: An insight. 
Med J Armed Forces India 2010;66:152-7.
7. Goldsmith JP. Continuous positive airway pressure and conventional 
mechanical ventilation in the treatment of meconium aspiration syndrome. 
J Perinatol 2008;28 Suppl 3:S49-55.
8. Velaphi S, Vidyasagar D. Intrapartum and postdelivery management 
of infants born to mothers with meconium-stained amniotic fluid: 
Table 2: CPAP parameters before and after 6 h
CPAP parameters At the start 
of CPAP
6 h 
post-CPAP
p-value
Downe’s score 6±0.45 4±0.50 <0.001
FiO2 (%) 68±22 48±20 <0.001
RR/min 76±12 48±18 <0.001
Heart rate (beats/min) 181±11 123±18 <0.001
Values express in number/percentage (%). CPAP: Continuous positive airway pressure
Ahmed et al. Bubble continuous positive airway pressure 
Vol 6 | Issue 12 | December 2019 Indian J Child Health 672
Evidence-based recommendations. Clin Perinatol 2006;33:29-42.
9. Singh BS, Clark RH, Powers RJ, Spitzer AR. Meconium aspiration 
syndrome remains a significant problem in the NICU: Outcomes and 
treatment patterns in term neonates admitted for intensive care during a ten-
year period. J Perinatol 2009;29:497-503.
10. Fox WW, Berman LS, Downes JJ Jr., Peckham GJ. The therapeutic 
application of end-expiratory pressure in the meconium aspiration syndrome. 
Pediatrics 1975;56:214-7.
11. Malik R, Gupta R. A two year experience in continuous positive airway 
pressure ventilation using nasal prongs and pulse oximetry. Med J Armed 
Forces India 2003;59:36-9.
12. Bhagwat P, Murki S, Mehta A, Oleti T, Dhanraj D. Continuous positive 
airway pressure in meconium aspiration syndrome: An observational study: 
An observational study. J Clin Neonatol 2015;4:96-100.
13. Pandita A, Murki S, Oleti TP, Tandur B, Kiran S, Narkhede S, et al. 
Effect of nasal continuous positive airway pressure on infants with 
meconium aspiration syndrome: A randomized clinical trial. JAMA Pediatr 
2018;172:161-5.
14. Manandhar SR. Outcome of respiratory distress in neonates with bubble 
CPAP at neonatal intensive care unit of a tertiary hospital. JNMA J Nepal 
Med Assoc 2019;57:92-7.
Funding: None; Conflicts of Interest: None Stated.
How to cite this article: Ahmed FKR, Jeergal NA, Channakeshava D, 
Reddy LN. Bubble continuous positive airway pressure as a primary modality 
of respiratory support in meconium aspiration syndrome. Indian J Child 
Health. 2019; 6(12):669-672.
Doi: 10.32677/IJCH.2019.v06.i12.008
